The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience

Table 1

Showing cumulative results.

Test/Results	Positive	Indeterminate	Negative	Not recorded
QTB	1 (4.3%)	2 (8.7%)	20 (87%)	—
CXR	0	0	23 (100%)	0
TST	0	0	14 (61%)	9 (39%)
BCG	5 (22%); (scar present)	—	—	18 (78%)
Risk assessment	3 (13%) (high)	—	20 (87%); (low)	0